|
|
|
|
|
| April 22 ,
2010 | ISSUE NUMBER 145 VOL 8 |
Sales
Updated IMS Forecast Predicts Market Growth
After a slight dip in growth during 2010, IMS anticipates the global pharma market will reach $1.1 trillion by 2014.
FDA
Avandia Trial in Trouble
The hits keep coming for GSK’s diabetes drug as FDA takes a closer look at the ethics of one of its safety trials.
Healthcare
Lower Lilly Earnings the Shape of Things to Come
Lilly’s first quarter numbers dipped from last year, citing, among other factors, increased costs due to US healthcare reform. And a report from Express Script says this is just the beginning.
CME
Government to Launch Academic Detailing Program
The Agency for Healthcare Research and Quality is set to begin a massive initiative to educate medical professionals in the fall.
Call for Nominations
Pharmaceutical Executive¹s Emerging Pharma Leadership Award
The pharma industry is facing some tough times‹and the old way of doing things just won¹t work. So just who are the new leaders steering the industry though its most difficult challenges? Which executives are revamping the industry‹through pure innovation‹to remake it for the 21st century?
These emerging leaders are vital to the future of the industry, and you can help ensure that they get the recognition they deserve. Fill out your nomination today! |
|
 |
| 
|
 // Atacama Labs Oy appointed Robert Lammens chief technology officer.
// Ikaria Holdings elected Howard Pien to its board as an independent member.
// Ampio Pharmaceuticals appointed Philip Coelho to its board of directors.
// Silence Therapeutics hired Max Herrmann as CFO.
// Dendreon hired Richard Ranieri as SVP of human resources.
// Renhuang Pharmaceuticals added Sean Shao to its board of directors and named him chairman of its audit committee.
// Sangamo Biosciences elected William Ringo chairman of the board.
// Mark Kontny joined Pantheon as president of global pharmaceutical development services and chief scientific officer.
// Oncopeptides AB elected Alan Hulme chairman of the board.
// Vermillion hired Sandra Gardiner as CFO.
// Renhuang Pharmaceuticals appointed Changxiong Sun and Bingchun Wu to its board as independent directors.
// Cumberland Pharmaceuticals elected Gordon Bernard, Jonathan Griggs, and James Jones to its board.
// Marketing Technology Solutions rebranded itself as QualityHealth and hired Elaine Boxer as SVP, marketing strategy.
// |
 |
|
May 17–18, 2010 Sales Force Effectiveness USA
Princeton, New Jersey
June 13–17, 2010 Drug Industry Association’s Annual Meeting, Washington DC
June 29–30, 2010 Biorbis: Unlocking the Potential of Cancer Vaccines, Cambridge, Massachusetts |
|
|
|
 |
|
 |
|
 |
| If you plan to enter emerging markets over the next 3 years, what will be your primary entry strategy? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
